DOI:
10.1055/s-00000145
Dialyse aktuell
LinksClose Window
References
Van Vollenhoven RF, Hahn BH, Tsokos GC. et al
Maintenance of efficacy and safety of ustekinumab through 1 year in a randomized phase II trial of patients with active systemic lupus erythematosus.
Arthritis Rheumatol 2020;
72: 761-768 doi:10.1002/art.41179
We do not assume any responsibility for the contents of the web pages of other providers.